Navigation Links
Gastrointestinal Disorders Therapeutics to 2016 - High Unmet Needs Triggering Strong Growth in Crohn's Disease and Irritable Bowel Syndrome Markets Now Available at ReportsandReports
Date:6/28/2010

Analysis 68 10 Global GERD Therapeutics Market 69 10.1 Market Overview 69 10.2 Market Forecasts 69 10.3 Annual Cost of Treatment 71 10.4 Usage Patterns 72 10.4.1 Diseased Population 72 10.4.2 Treatment Seeking Population 73 10.4.3 Diagnosis Population 74 10.4.4 Prescription Population 75 10.4.5 Threapy Usage Patterns 76 10.5 Product Analysis 77 10.5.1 Nexium (esomeprazole) 77 10.5.2 Aciphex (rabeprazole sodium) 77 10.5.3 Prevacid (lansoprazole) 77 10.5.4 Prilosec (omeprazole) 78 10.5.5 Protonix (pantoprazole sodium) 78 10.5.6 Tagamet (cimetidine) 78 10.5.7 Pepcid (famotidine) 78 10.5.8 Zantac (ranitidine hydrochloride) 78 10.5.9 Axid (nizatidine) 78 10.6 Drug Pipeline Analysis 79 11 Global Crohn's Disease Therapeutics Market 80 11.1 Market Overview 80 11.2 Market Forecasts 81 11.3 Annual Cost of Treatment 82 11.4 Usage Patterns 83 11.4.1 Diseased Population 83 11.4.2 Treatment Seeking Population 84 11.4.3 Diagnosis Population 86 11.4.4 Prescription Population 87 11.4.5 Therapy Usage Patterns 88 11.5 Product Analysis 89 11.5.1 Entocort EC (budenoside) 90 11.5.2 Humira (adalimumab) 90 11.5.3 Tysabri (natalizumab) 90 11.5.4 Remicade (infliximab) 90 11.5.5 Cimzia (cetrolizumab pegol) 91 11.6 Drug Pipeline Analysis 91 12 Global Gastrointestinal Disorder Therapeutics Market: Market Drivers and Restraints 92 12.1 Market Drivers 92 12.1.1 Steady Increase in the Elderly Population 93 12.1.2 Stable Increase in Incidence Rates for Gastrointestinal Disorders 93 12.1.3 Increase in Awareness Levels of Disease Progression and Etiology 93 12.2 Market Restraints 93 12.2.1 Entry of Generics Pose a Serious Problem for Primary Manufacturers 94 12.2.2 Presence of Serious Side Effects for Certain Classes of Therapeutic Drugs 94 13 Global Gastrointestinal Disorder Therapeutics Market
'/>"/>
SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related biology technology :

1. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
2. ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs
3. Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
4. DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD
5. Soligenix Announces Grant of Broad European Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
6. New Study Showed the Impact of Gastrointestinal Disorders in Patients With Parkinsons Disease
7. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
8. TAP Pharmaceutical Products Inc. Files New Drug Application for TAK-390MR in Patients with Acid-Related Disorders
9. Synosia Announces Encouraging Results of Proof-of-Concept Clinical Trial for Epilepsy Drug rufinamide as a Treatment for Mood Disorders
10. SleepQuest Raises Awareness of Sleep Disorders
11. S*BIO Receives Orphan Drug Designation for JAK2 Inhibitor SB1518 for the Treatment of Myeloproliferative Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... Inc. (NASDAQ: SGMO ) today reported its ... For the second quarter ended June 30, 2014, ... or $0.10 per share, compared to a net loss ... same period in 2013. As of June 30, 2014, ... interest receivable of $236.7 million. Revenues for ...
(Date:7/23/2014)... Ill. , July 23, 2014 /PRNewswire/ ... (SNA™) constructs as gene regulatory and immunotherapeutic ... has joined AuraSense Therapeutics, executive leadership ... 11. Prior to joining AuraSense ... and Chief Financial Officer of Cellular Dynamics ...
(Date:7/23/2014)... Jolla, CA (PRWEB) July 23, 2014 ... stem cell therapy in the US aimed at improving ... announced their newest clinical study for Parkinson’s disease. ... efficacy of stem cell therapy are paramount when providing ... This clinical study makes stem cell therapy accessible to ...
(Date:7/23/2014)... , July 23, 2014 ... ), the global specialty biopharmaceutical company, and ArmaGen, ... a worldwide licensing and collaboration agreement for AGT-182, ... potential treatment of both the central nervous system ... syndrome (MPS II). This collaboration strengthens Shire,s rare ...
Breaking Biology Technology:Sangamo BioSciences Reports Second Quarter 2014 Financial Results 2Sangamo BioSciences Reports Second Quarter 2014 Financial Results 3Sangamo BioSciences Reports Second Quarter 2014 Financial Results 4Sangamo BioSciences Reports Second Quarter 2014 Financial Results 5Sangamo BioSciences Reports Second Quarter 2014 Financial Results 6Sangamo BioSciences Reports Second Quarter 2014 Financial Results 7Sangamo BioSciences Reports Second Quarter 2014 Financial Results 8Sangamo BioSciences Reports Second Quarter 2014 Financial Results 9AuraSense Therapeutics Appoints Biotechnology Veteran David S. Snyder as Chief Financial Officer 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 3Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 2Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 3Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 4Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 5
... issues going on right now, it could be helpful ... yesterday's critical moments. , ,There are many quotes ... are worth applying to your position in management, education, ... of things. That's very important in today's global economy. ...
... are men of action. Lies do not become us." , ... ,Small business owners sometime seem like a big challenge to ... Given the right opportunity, however, small business owners can also ... present a desirable and growing market to many businesses. According ...
... Wis. - The exodus continues at Merge Technologies, ... does business as Merge Healthcare, has announced that it received ... interim co-president and co-CEO, and president of Merge subsidiary ... of business on Aug. 18. , ,Pedlar is the fifth ...
Cached Biology Technology:Business leaders can learn from historical insights 2Business leaders can learn from historical insights 3Business leaders can learn from historical insights 4Business leaders can learn from historical insights 5Big opportunities with small businesses 2Big opportunities with small businesses 3Pedlar the latest executive to leave Merge 2
(Date:7/23/2014)... from North Carolina State University shows that urban "heat ... United States. One factor is that researchers have found ... the gloomy scale insect a significant tree pest ... 200 times more adult gloomy scales on urban trees. ... like the gloomy scale in cities, and now we ...
(Date:7/23/2014)... NEWPORT, Ore. -- A comprehensive 15-year analysis of the ... of the United States found that their favored feeding ... the threat of injury and mortality. , The researchers ... and San Francisco to slightly different areas at ... most abundant could significantly decrease the probability of ...
(Date:7/23/2014)... , , , , ... , , , , ... medical care is delivered could help prevent multiple chronic diseases and extend healthy lifespan. The idea, they argue, would be to target the... , ... , , , , ... , , , , , ...
Breaking Biology News(10 mins):Urban heat boosts some pest populations 200-fold, killing red maples 2Urban heat boosts some pest populations 200-fold, killing red maples 315-year analysis of blue whale range off California finds conflict with shipping lanes 215-year analysis of blue whale range off California finds conflict with shipping lanes 315-year analysis of blue whale range off California finds conflict with shipping lanes 4Strategy proposed for preventing diseases of aging 2Strategy proposed for preventing diseases of aging 3Strategy proposed for preventing diseases of aging 4Strategy proposed for preventing diseases of aging 5
... news release is available in French . ... eggs, and dairy products, was until now considered non-essential because it ... Montreal and its affiliated CHU Sainte-Justine Hospital found that the amino ... case for other organs. "The cells of the body can do ...
... Shenzhen, China - In a paper published in ... Science and Technology, Korea Genome Research Foundation, BGI, and ... and their new findings on how whales successfully adapted ... will contribute to future studies of marine mammal diseases, ...
... the smallest parts of the brain is getting a second ... in decision making. A University of British Columbia study ... habenula, a region of the brain linked to depression and ... in cost-benefit decisions. "These findings clarify the brain processes ...
Cached Biology News:Meat, egg and dairy nutrient essential for brain development 2Meat, egg and dairy nutrient essential for brain development 3New genomic study provides a glimpse of how whales could adapt to ocean 2Scientists find brain region that helps you make up your mind 2
... Strips have hydrophobic plastic supports that ... contact with toxic/hazardous solutions. Paper segments on ... leach into solution. Complementary indicator charts provide ... graduated in 1pH units; In packs of ...
Recorder REC-111 single-channel, 1. Category: Chromatography Systems & Accessories, Systems....
... service is for when you need to make ... their transformation efficiency. Our services for preparing competent ... applications. MCLab's custom competent cell service offers: ... Fast turnaround Quality control ...
Fast, sensitive quantitation of total MEK 1/2 concentration....
Biology Products: